Prognose

Vi har ingen analytikerdata for denne virksomhed.

Nyheder Til nyhedsfeedet

Syncona issues 9,330 new shares for long-term incentive plan

Syncona has announced the issuance of 9,330 new ordinary shares to meet obligations under a long-term incentive plan. The new shares represent around 0.002% of existing ordinary shares and were calculated based on a mid-price of £1.07 per share; recipients may not sell or transfer the shares for one year. The company has applied for admission to the official market; trading is expected to commence on Thursday. » Mere på de.investing.com
Syncona shareholders approve new investment strategy and long-term incentive schemes

Shareholders of Syncona approved the new investment strategy with around 89.6% and the new long-term incentive schemes with 89.4%. As of the record date there were 672,549,420 issued ordinary shares, of which 64,356,396 were treasury shares; voting rights amounted to 608,193,024. Rob Hutchinson has resigned from the board; the board intends to appoint a new non-executive member with investment company expertise and to keep the total number of members at five. All resolutions passed at the general meeting will be submitted to the National Storage Mechanism and are set out in the explanatory circular. » Mere på de.investing.com
Syncona to ask shareholders to vote on new investment policy and remuneration structure on March 3

Syncona is putting proposals to shareholders to change its investment policy and the investment team's remuneration. Plans include a review of capital allocation within two years or after the return of £250m, and a cap on new investments in early-stage companies at £15m each for the financial years ending September 2026 and 2027 and a maximum of 5% of NAV as of 30 September 2025. The new remuneration structure ties bonuses to the realisation of portfolio assets and allows partial payments in market-purchased Syncona shares. The Wellcome Trust, with around 30.58% of voting rights, has announced its support. » Mere på de.investing.com

Historisk udbytte Udbytte

Alle nøgletal for udbytte Alle nøgletal

I 2019 har SYNCONA LS allerede udloddet 0,0252 € i udbytte. Den seneste udlodning fandt sted i juli 2019.

Virksomhedstal

I det seneste kvartal havde SYNCONA LS en omsætning på 42,72 mio. € og et nettoresultat på 19,06 mio. €

(EUR)	marts 2026	YoY
Omsætning	42,72 mio.	-
Bruttofortjeneste	42,72 mio.	-
Nettoresultat	19,06 mio.	-
EBITDA	19,06 mio.	-

Fundamentale data

Nøgletal	Værdi
Markedsværdi	796,03 mio. €
Antal aktier	608,19 mio.
Højeste/laveste i 52 uger	1,37 € - 1,01 €
Udbytte	Nej
Beta	0,36
P/E (PE Ratio)	-77,78
PEG (PEG Ratio)	-0,50
K/I (PB Ratio)	0,66
P/S (PS Ratio)	11,88

Virksomhedsprofil

Syncona Limited ist ein Fonds, der auf Investitionen in Hedge-, Aktien- und langfristige alternative Investmentfonds in verschiedenen Anlageklassen spezialisiert ist. Er verwaltet Private Equity, Schuldtitel, festverzinsliche und alternative Anlagen. Der Fonds investiert vorzugsweise in den Gesundheits- und Biowissenschaftssektor mit Schwerpunkt auf Zelltherapie, Gentherapie, Biologika und kleinen Molekülen. Der Fonds investiert weltweit in die öffentlichen Aktien- und Rentenmärkte. Er strebt attraktive mittel- bis langfristige Renditen an, indem er in führende Long-only- und alternative Investmentfonds mit bewährten Managern und über mehrere Anlageklassen hinweg investiert. Das Unternehmen investiert in separat verwaltete Kontenportfolios.